Showing 25–27 of 27 results

Vizimpro 45 mg Alternative – Dacocent (Dacomitinib) 45 mg Tablet | Incepta Pharmaceuticals

Dacocent 45 mg (Dacomitinib) by Incepta Pharmaceuticals. EGFR inhibitor for selected EGFR-mutated NSCLC. Reference brand: Vizimpro (Pfizer). Pack: 10 tablets. Prescription only; equivalence not established.

Xalkori 250 mg Alternative – Crizocent (Crizotinib) 250 mg Capsule | Incepta Pharmaceuticals

Crizocent 250 mg (Crizotinib) Capsule is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Xalkori (Pfizer).

Pack: 12 capsules. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Xgeva 120 mg Alternative – Denosis (Denosumab) 120 mg Injection | Incepta Pharmaceuticals

Denosis 120 mg (Denosumab) Injection is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Xgeva (Amgen).

Pack: 1 vial. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.